0
ARTICLE |

GRISEOFULVIN FOR THE SYSTEMIC TREATMENT OF DERMATOMYCOSES

Harvey Blank, M.D.; J. Graham Smith, M.D.; Frank J. Roth, Ph.D.; Nardo Zaias, M.D.
JAMA. 1959;171(16):2168-2173. doi:10.1001/jama.1959.03010340012003.
Text Size: A A A
Published online

Griseofulvin, an antibiotic obtainable from at least four kinds of Penicillium, has been found effective in certain experimental fungous infections of animals as well as in fungous diseases of man. It was used in 200 patients with superficial fungous infections at 311 sites of major involvement. The organism most frequently found was Trichophyton rubrum, identified in 185 sites. The dosage of griseofulvin varied from 0.5 to 1.0 Gm. by mouth. One gram per day is recommended. When the lesions did not involve the nails, palms, or soles, three weeks of therapy usually was adequate. Even with lesions of the palms and soles, relief from itching occurred in two to six days; vesicles and scales disappeared and cultures usually became negative in two to six weeks. It was necessary to keep in mind the fact that nails grow slowly and that the fungous infection may be superposed on other disease. Until more experience with this drug accumulates, monthly blood counts are advised, but in this series no significant manifestations of toxicity were noted.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs